BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32436722)

  • 1. Impact of family history risk assessment on surgical decisions and imaging surveillance at breast cancer diagnosis.
    Jones S; Turton P; Achuthan R
    Ann R Coll Surg Engl; 2020 Oct; 102(8):590-593. PubMed ID: 32436722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
    Kishan AU; Gomez CL; Dawson NA; Dvorak R; Foster NM; Hoyt A; Hurvitz SA; Kusske A; Silver EL; Tseng C; McCloskey SA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):634-641. PubMed ID: 27619940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the management of people with a family history of breast cancer in primary care: before and after study of audit-based education.
    Rafi I; Chowdhury S; Chan T; Jubber I; Tahir M; de Lusignan S
    BMC Fam Pract; 2013 Jul; 14():105. PubMed ID: 23879178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effectiveness of NICE criteria for stratifying breast cancer risk in a UK cohort.
    Littlejohn LA; Gibbs J; Jordan LB; Miedzybrodzka ZH; Bell C; Goudie D; Dunlop J; Berg JN
    Eur J Hum Genet; 2018 Apr; 26(4):599-603. PubMed ID: 29335492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.
    Lanceley A; Eagle Z; Ogden G; Gessler S; Razvi K; Ledermann JA; Side L
    Int J Gynecol Cancer; 2012 Feb; 22(2):254-9. PubMed ID: 22274317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history of breast cancer and its association with disease severity and mortality.
    Melvin JC; Wulaningsih W; Hana Z; Purushotham AD; Pinder SE; Fentiman I; Gillett C; Mera A; Holmberg L; Van Hemelrijck M
    Cancer Med; 2016 May; 5(5):942-9. PubMed ID: 26799372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?
    Teixeira N; van der Hout A; Oosterwijk JC; Vos JR; ; Devilee P; van Engelen K; Meijers-Heijboer H; van der Luijt RB; Kriege M; Mensenkamp AR; Rookus MA; van Roozendaal KE; Mourits MJE; de Bock GH
    Eur J Hum Genet; 2018 Jun; 26(6):848-857. PubMed ID: 29483665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A primary care audit of familial risk in patients with a personal history of breast cancer.
    Nathan P; Ahluwalia A; Chorley W
    Fam Cancer; 2014 Dec; 13(4):591-4. PubMed ID: 25096803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer.
    Schwab FD; Bürki N; Huang DJ; Heinzelmann-Schwarz V; Schmid SM; Vetter M; Schötzau A; Güth U
    Fam Cancer; 2014 Mar; 13(1):99-107. PubMed ID: 24002368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial breast cancer: an investigation into the outcome of treatment for early stage disease.
    Eccles D; Simmonds P; Goddard J; Coultas M; Hodgson S; Lalloo F; Evans G; Haites N
    Fam Cancer; 2001; 1(2):65-72. PubMed ID: 14573999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal or first-degree family breast cancer history: which has higher impact on tumor detection and tumor size in breast cancer.
    Schwab FD; Kilic N; Huang DJ; Schmid SM; Vetter M; Schötzau A; Güth U
    Arch Gynecol Obstet; 2015 Jun; 291(6):1387-94. PubMed ID: 25516178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does family history influence survival in breast cancer cases?
    Russo A; Herd-Smith A; Gestri D; Bianchi S; Vezzosi V; Rosselli Del Turco M; Cardona G
    Int J Cancer; 2002 May; 99(3):427-30. PubMed ID: 11992413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is family history related to preventive health behaviors and medical management in breast cancer patients?
    Madlensky L; Flatt SW; Bardwell WA; Rock CL; Pierce JP;
    Breast Cancer Res Treat; 2005 Mar; 90(1):47-54. PubMed ID: 15770526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher levels of central adiposity in healthy premenopausal women with family histories of premenopausal breast cancer.
    Dettenborn L; James GD; Britton JA; Bovbjerg DH
    Am J Hum Biol; 2008; 20(3):355-8. PubMed ID: 18161037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynaecological cancer pathway for faster cancer treatment: a clinical audit.
    Askew C; Gangji A
    N Z Med J; 2016 Oct; 129(1444):79-89. PubMed ID: 27806031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Genetic Counseling in Women with a Family History of Breast Cancer in Italy.
    Godino L; Razzaboni E; Bianconi M; Turchetti D
    J Genet Couns; 2016 Apr; 25(2):405-11. PubMed ID: 26354337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma.
    Lee Y; Jeon JH; Goh SH; Roh H; Yun JY; Kwon NJ; Choi JH; Yang HC; Kim MS; Lee JM; Lee GK; Han JY
    Lung Cancer; 2019 Oct; 136():15-22. PubMed ID: 31421257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.
    Alhassan B; Rjeily MB; Villareal-Corpuz V; Prakash I; Basik M; Boileau JF; Martel K; Pollak M; Foulkes WD; Wong SM
    Ann Surg Oncol; 2024 Feb; 31(2):981-987. PubMed ID: 37973648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.
    Teixeira N; Mourits MJ; Vos JR; Kolk DM; Jansen L; Oosterwijk JC; Bock GH
    Maturitas; 2015 Oct; 82(2):197-202. PubMed ID: 26239500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.